Drug Discovery

#AI / data analytics / healthtech / informatics #Drug discovery #Lab automation #Podcast

Podcast: What do we know about lab automation? 

The latest episode of the free DDW podcast is titled“What do we know about lab automation?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW, read by Megan Thomas.   The articles are “What has 2020 taught us… Read More

#News

#Approvals #Collaboration #Drug discovery #Public health #Research study

This week in drug discovery (14-18 February) 

News round-up by DDW’s Megan Thomas for 14-18 February, 2022  This week, DDW rounds up updates, approvals, research and trials which will enable scientists to make life-saving developments in the drug discovery industry.  1. Trial launched of HIV vaccine antigens delivered through mRNA technology… Read More

#News

#Biologics #Drug discovery

With biologic drug discovery mounting, CAS announces expansion 

CAS, a division of the American Chemical Society specialising in scientific information solutions, has launched an expansion of the CAS SciFinder Discovery Platform into life sciences. The enhanced platform includes over two million modified biosequences, 60 years of patent literature, and one of the largest collections of journal information… Read More

#News

#Biotechnology #DNA #Drug discovery #mRNA #Synthetic chemistry

From synthetic biology to synthesising DNA: helping advance research 

Evonetix is reimagining biology. Dr Vijay Narayan, Head of Physics, Dr Stuart Crosby, Head of Synthetic Chemistry, and Daniel Bygrave, Principal Software Engineer, offer insight into the technology being developed by the company and its relevance for researchers.  “I have always been intrigued by interdisciplinary environments,’… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Intelligence #News #Trends & Analysis

#Collaboration #Drug discovery

This week in drug discovery (7-11 February) 

News round-up by DDW’s Megan Thomas for 7-11 February, 2022  This week has proved eventful in terms of progression in the drug discovery industry. DDW’s Megan Thomas flags five news stories which display this.  1. Additional dose of Covid-19 vaccine is safe, says US trial … Read More

#News #Trending News

#Biotechnology #Drug discovery #eBook #Lab automation

eBook: Your essential guide to drug discovery technology

This 28-page DDW eBook, sponsored by Bio-Rad, contains exclusive insight from industry experts on what’s new in lab automation and how this technology can accelerate your drug discovery process and is available to download now. With this guide, you can learn more about: The benefits of automation and how to… Read More

#News #Trending News

#CRO #Drug development #Drug discovery #Genomics

CROs: Drug discovery expertise on hand  

Listen to this article on the DDW Podcast: Lu Rahman asks Laura Hinton, Operations Director at Gentronix, to offer some insight into the contract research organisation (CRO) market and how Gentronix is making its presence known in this sector.  Gentronix is a specialist contract research organisation (CRO) based in the UK, focused on delivering… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Collaboration #Drug discovery #Oncology

Drug discovery collaboration to progress inhibitor project  

Domainex has supported the collaboration between Queen’s University Belfast (UK) and Ipsen to research, develop, manufacture and commercialise FLIP inhibitors – a programme that Domainex has supported since its inception.  Background  At the start of the project, Domainex conducted a LeadBuilder virtual screen that generated the initial hit matter. Read More

#News

#Drug discovery #Drug research #Drug targets

This week in drug discovery (31 January – 4 February) 

News round-up by DDW’s Megan Thomas for 31 January – 4 February, 2022  This week, DDW’s Megan Thomas has rounded up five stories that highlight the impact of research, breakthroughs, agreements and trials in the drug discovery world.  1. Researchers discover way to disarm… Read More

#News

#Autoimmune disease #Drug discovery #Research

Study profiles side-effects linked to common immunosuppressant 

New research led by scientists from the UK’s University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) has profiled the side effects of methotrexate – a common drug used to treat arthritis and other autoimmune diseases.   The findings  The authors hope their findings –… Read More

#News

#Drug discovery #Eye health #iPSC #Ophthalmology #Partnership

Evotec enters ophthalmology drug discovery partnership 

Evotec has entered a target and drug discovery partnership with Boehringer Ingelheim, focusing on induced pluripotent stem cell (iPSC)-based disease modelling for ophthalmologic disorders.   Context   Millions of people are affected by vision-related diseases worldwide, and there is a high unmet need for novel therapeutic solutions. … Read More

#News

Bacteria
#Drug development #Drug discovery #Events #Microbiome #Therapeutics

Take aways from Microba’s presentation at European summit

Microba Life Sciences, a precision microbiome science company based in Australia, showcased its therapeutic platform and discovery platform for the identification of novel microbial signatures at Microbiome Movement, a European drug development summit, on January 27.  The event  The event brought together researchers from the biopharmaceutical… Read More

#News

Laboratory mouse
#Biosciences #Drug discovery #Podcast

How to accelerate mouse model generation – podcast

The latest DDW Sitting Down With sponsored podcast features Dominque Bröhl and Evert-Jan Uringa, Scientific Program Managers at Taconic Biosciences, who discuss how mouse model generation can be accelerated without any loss of quality. They offer insight into the latest developments, innovation and challenges in mouse model generation, how… Read More

#News

#Collaboration #Comment #Drug discovery #Lab automation #SLAS2022

Comment: SLAS’ strength is collaboration 

The Winter issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, US on 5-9 February. As we all look forward to the expertise at the event, Jill Hronek, Director of Marketing and Communications at SLAS, comments that collaboration has always… Read More

#Editor's Choice #Exclusive Content #News

#AI / data analytics / healthtech / informatics #Drug discovery #Video

Video: Insights into structure and sequence activity 

Signals Inventa is a next-generation data management system for the analysis of scientific results. PerkinElmer has released a video that explains how this platform works.   The video shares how Signals Inventa provides a faster way to help chemists gain insights into structure and sequence activity relationships… Read More

#News